<<Prev Rule

Texas Administrative Code

Next Rule>>
TITLE 22EXAMINING BOARDS
PART 15TEXAS STATE BOARD OF PHARMACY
CHAPTER 315CONTROLLED SUBSTANCES
RULE §315.5Pharmacy Responsibility - Generally

(a) Upon receipt of a properly completed prescription form, a dispensing pharmacist must:

  (1) if the prescription is for a Schedule II controlled substance, ensure the date the prescription is presented is not later than 30 days after the date of issuance;

  (2) if multiple prescriptions are issued by the prescribing practitioner allowing up to a 90-day supply of Schedule II controlled substances, ensure each prescription is neither dispensed prior to the earliest date intended by the practitioner nor dispensed beyond 30 days from the earliest date the prescription may be dispensed;

  (3) record the date dispensed and the pharmacy prescription number;

  (4) indicate whether the pharmacy dispensed to the patient a quantity less than the quantity prescribed; and

  (5) if issued on an official prescription form, record the following information, if different from the prescribing practitioner's information:

    (A) the brand name or, if none, the generic name of the controlled substance dispensed; or

    (B) the strength, quantity, and dosage form of the Schedule II controlled substance used to prepare the mixture or compound.

(b) The prescription presented for dispensing is void, and a new prescription is required, if:

  (1) the prescription is for a Schedule II controlled substance, 30 days after issuance, or 30 days after any earliest dispense date; or

  (2) the prescription is for a Schedule III, IV, or V controlled substance, more than six months after issuance or has been dispensed five times during the six months after issuance.


Source Note: The provisions of this §315.5 adopted to be effective March 10, 2016, 41 TexReg 1690; amended to be effective June 9, 2021, 46 TexReg 3521

Link to Texas Secretary of State Home Page | link to Texas Register home page | link to Texas Administrative Code home page | link to Open Meetings home page